Member Info for krafty1305

For years cancer vaccines were considered a no go area. so this exposure is a great thing as we obviously think ours is better and universal, cheaper and currently with better results subject to expansion of trial.

Modi2 revealed to a wider audience today. big landmark for company

I wonder if someone can help me. Some discussion on what moditope can do based on trial results so far. What we have had is a trial of moditope 1 on the hardest to treat cancers building up the dose level and evolving now to a combo trial. Today's poster is on moditope 2 and its effect on solid tumours. The excitement around Moditope has always been it will make the solid tumours melt away. Now to my lay/autistic brain that sounds like moditope 2. So can someone please explain to me the difference between moditope 1 and 2. There may have been some confusion between the two and what they are supposed to do. IE: moditope 1 was never going to do what moditope 2 can. IE they are different, do different things and so on and are for different types of patients. Any help explaining I would be most grateful

What’s a good price sensibly

Meanwhile it has ticked down.. please stop misleading people. will stop the positive mood. no more short term predictions please.

Early days for moditope and from what i interpreted from what Scancell have told us Modi 2 will be the one that melts those heavy tumours. look how immunobody has evolved

Hopefully day traders have done what they need to do and taken their 15%!

2 days after a very positive RNS last week. I suggest you read it again word for word instead of eating yourself up about conspiracy theories. it's all in there. today is conformation with some more meat on the bones. then read recruitment RNS's. again loads of clues. just admit you read it wrong and others were bullish after the 3 bullish RNS's so far before today.

I would hope that we could get some proper news coverage this time, be it press, radio or TV. That would help next leg up for SP. I assume that is what today's press conference is all about. Our chairman's experience is all over this.

Price fell from over 14p to 9p in 2 weeks in july. was that based on inside information

They told us great progress was being made in the trials only last week some believed them and backed it with their cash. All today has done is put numbers on it. the clues have been there all along. Suggest you pay more attention

Predictions for today?

Wow!

Bid bounced off 13p pretty quick to 13.66, so may be

Surely the only thing that would do this outside of a mega rns is someone trying to build a stake. all comments appreciated from more experienced investors than me

Keeps going north 13.25/13.50 now. normally a pull back by now

Is there any chance of an RNS before Thursday's posters or will they be based on what we already know

Had my covid top yesterday, so would agree

Multi trials ongoing on key products to be kept in-house for now

licensing deals on existing products actively being negotiated

New infrastructure in place to focus resources where required as opposed to being spread too thin.

I would suggest our new CEO is doing a rather good job in helping Scancell mature

Abcam being sold for $5.7bn which in our terms I think is about £5 a share. That would do!